AOCO-KSSO Symposia

AOCO-KSSO Symposium 1
Diverse aspects of Locaserin

Chairperson: Kyung-Soo KIM (The Catholic University of Korea, Korea)
Kuo-Chin HUANG (National Taiwan University, Taiwan)

Room 4 / 30 August 2019 (Fri)

09:10-09:40

Evidenced-based pharmacotherapy for obesity in Asia - a multicenter, placebo-controlled trial of lorcaserin
Wen-Yuan LIN (China Medical University, Taiwan)
09:40-10:10

The clinical experience of locaserin in Korea
Kyoung-Kon KIM (Gachon University, Korea)
10:10-10:40

The ABCs of Serotonin agonism and the development of a safe anorexigenic agent
Bruce H FRANCIS (Ben Gurion University, Israel)

AOCO-KSSO Symposium 2
GLP-1 RAs as anti-obesity drugs: hope or hype

Chairperson: Jeong-Taek WOO (Kyung Hee University, Korea)
Arne ASTRUP (University of Copenhagen, Denmark)

Room 4 / 30 August 2019 (Fri)

14:30-15:00

Clinical use of GLP-1 RAs as anti-obesity drugs: learning from local cases
Francis Chun Chung CHOW (Chinense University of Hong Kong, Hong Kong)
15:00-15:30

Real world experience of a GLP-1 receptor agonist as anti-obesity drug in Korea
Soo LIM (Seoul National University, Korea)
15:30-16:00

Clinical experience in the use of glucagon like peptide 1 (GLP-1) receptor analogues for obesity management
Tania MARKOVIC (Royal Prince Alfred Hospital Medical Centre, Australia)